Evidence map›Paper›PMID 41731296›Full record

ArticleAAPS PharmSciTech2026

Overcoming the Challenges of Viscous Simulated Fed State Media with a Computerized Numerical Control Tablet Disintegration and Dissolution Tester.

Valentin Stahl, Muhammad Farooq Umer, Jozef Al-Gousous, Thomas Nawroth, Wei-Jhe Sun, Fang Wu, Wenlei Jiang, Zongming Gao, Peter Langguth

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Valentin StahlDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University Mainz, Staudingerweg 5, 55099, Mainz, Germany. valstahl@uni-mainz.de.ORCID http://orcid.org/0009-0008-8451-6579
Muhammad Farooq UmerDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University Mainz, Staudingerweg 5, 55099, Mainz, Germany.ORCID http://orcid.org/0000-0002-2715-8823
Jozef Al-GousousDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University Mainz, Staudingerweg 5, 55099, Mainz, Germany.ORCID http://orcid.org/0000-0001-7994-4175
Thomas NawrothDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University Mainz, Staudingerweg 5, 55099, Mainz, Germany.ORCID http://orcid.org/0000-0001-5721-3435
Wei-Jhe SunOffice of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, 20993, USA.ORCID http://orcid.org/0009-0005-3306-3096
Fang WuOffice of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, 20993, USA.ORCID http://orcid.org/0009-0009-1485-8386
Wenlei JiangOffice of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, 20993, USA.ORCID http://orcid.org/0009-0009-3876-638X
Zongming GaoOffice of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, USA, 20993.ORCID http://orcid.org/0009-0002-2038-7401
Peter LangguthDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University Mainz, Staudingerweg 5, 55099, Mainz, Germany.ORCID http://orcid.org/0000-0003-3758-7581

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In disintegration and dissolution (D&D) testing, high media viscosity, resembling ingested food, is rarely considered for simulated fed state investigations. However, it can strongly alter tablet breakdown and drug release, depending on the formulation factors. A viscous hydroxypropyl methyl cellulose (HPMC) solution as a D&D medium was used to match a blended FDA-standardized meal in terms of viscosity and pH, mimicking postprandial stomach content. However, compendial disintegration and dissolution apparatuses are not specifically designed to be operated with highly viscous media. Overall, tablet D&D performance is considerably slowed down due to high viscosity but is significantly influenced by the tablet's composition and physical properties, e.g., porosity. There are excipients that can increase coning already in fasted state media, for instance, insoluble fillers like microcrystalline cellulose or dicalcium phosphate. Under poor hydrodynamic conditions, those substances' negative effects can even be exacerbated. This leads to artefactual dissolution behavior, which did not align with expectations derived from the tablet's properties. A novel computerized numerical control (CNC)-based D&D apparatus is developed and applied to avoid these phenomena by moving the samples through the medium instead of fluid agitation around the tablet. The movement pattern is three-dimensional at a specified velocity and can be adjusted to desired conditions. Different test tablet formulations with varying soluble and insoluble fillers were used to demonstrate that the approach using the novel CNC apparatus overcomes the challenges of highly viscous media and clearly distinguishes tablets as expected, according to their composition.

Indexed as

TabletsCalcium PhosphatesCelluloseChemistry, PharmaceuticalDrug LiberationExcipientsHydrogen-Ion ConcentrationHypromellose DerivativesPorositySolubilityViscosityCalcium PhosphatesCelluloseExcipientsHypromellose Derivativesmicrocrystalline celluloseTabletsdisintegrationdissolutionfed statemedia viscositytablet formulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.